Pricing Log in Create free account
Friday 6 November 2026 Export PLSE’s income statement to Excel — free account

Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.

Revenue
+359.3%
EPS
−10.3%
Free cash flow
−1,180.5%

Quarter to September 2026, against a year earlier

53.15 3.91 −6.85%
Market cap
$3.9B
P/E
0.0×
Fwd P/E
−38.1×
Dividend yield
—
F-score
n/a
Altman Z
31.41
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Pulse Biosciences, Inc (PLSE) Total debt

Alert me on Total debt

Pulse Biosciences, Inc's total debt at the end of fiscal 2022 was $65.9M, up 485.9% from $11.3M in fiscal 2021. At the end of the quarter to 30 September 2023 it was $9.4M. Pulse Biosciences, Inc ranks 31st of 50 Medical Instruments & Supplies companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2022 $65.9M 485.93%
FY2021 $11.3M (0.93%)
FY2020 $11.4M 69.01%
FY2019 $6.7M —

Quarterly newest first

Period Total debt Change
Sep 2023 $9.4M (2.44%)
Jun 2023 $9.6M (85.38%)
Mar 2023 $65.8M (0.18%)
Dec 2022 $65.9M 1.26%
15 more quarters

Total debt against peers

Company Total debt
TFX Teleflex Incorporated compare $2.8B
NVST Envista Holdings Corporation compare $1.4B
ICUI ICU Medical, Inc. compare $1.2B
MMSI Merit Medical Systems, Inc. compare $737.4M
STVN Stevanato Group S.p.A. compare $545.0M
WRBY Warby Parker Inc. compare $170.2M
ATRC AtriCure, Inc. compare $61.0M
PLSE Pulse Biosciences, Inc $9.4M
MMED MiniMed Group, Inc. compare —

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on PLSE